Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Disease in Cape town
- A triple coincidence that leads to HIV-TB-IRIS
- Antiretroviral therapy improves immunity
- Pathological immunity may be restored by ART
- A wide range of IRIS conditions
- Two forms of IRIS associated with tuberculosis
- Paradoxical TB-IRIS
- Clinical manifestations of paradoxical TB-IRIS
- Histopathology of IRIS
- How significant is IRIS?
- Diagnosing IRIS
- Challenges in diagnosing IRIS
- Pathogenesis of TB-IRIS
- IFN-gamma secreting T cells and TB-IRIS (1)
- HIV-TB-IRIS and M. tuberculosis specific T cells
- T cell expansion & contraction in IRIS & non-IRIS
- T cell expansion further investigation
- IFN-gamma secreting T cells and TB-IRIS (2)
- What is the role of cytokines?
- Cytokine and MMP analysis
- Myeloid origin pro-inflammatory cytokines
- Supernatant cytokines of myeloid origin
- Myeloid origin serum pro-inflammatory cytokines
- Multiply elevated cytokines accompany TB-IRIS
- Management of TB-IRIS
- Randomized trial of prednisone vs. placebo
- Primary endpoint
- Secondary endpoints
- C-reactive protein
- Immunological analysis
- Th1 contraction & expansion: corticosteroids
- Interleukin-6
- Interleukin-10
- Interleukin-12p40
- Tumor necrosis factor
- Interferon-gamma
- Interferon gamma inducible protein 10 (CXCL10)
- Further evidence of innate immune involvement
- Suppurative necrosis may accompany TB-IRIS
- A potential role for neutrophils
- Uncharacteristic cavitation in HIV-TB
- MMP genes and endogenous inhibitors
- In vitro secretion of matrix metalloproteinases
- Serum level of matrix metalloproteinases
- Conclusions: MMP in TB-IRIS
- Conclusions: TB-IRIS
- Acknowledgements
Topics Covered
- TB-immune reconstitution inflammatory syndrome (IRIS) is a common complication of combined antitubercular and antiretroviral therapy
- The two forms of IRIS: paradoxical and unmasking
- Lack of a diagnostic test for TB-IRIS
- Expansion of Interferon gamma secreting T cells is associated with TB-IRIS
- Multiple cytokines are elevated in TB-IRIS, many of myeloid origin
- Benefits of adjunctive corticosteroid therapy in TB-IRIS
- Steroid therapy reduces the levels of IL-6, IL-10, IL-12p40, TNF, Interferon-gamma and CXCL-10 in TB-IRIS patients
- Suppurative necrosis may occur in TB-IRIS, implying a role for neutrophils
- Evidence of a prominent role for myeloid cells in the pathogenesis of TB-IRIS
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Wilkinson, R. and Meintjes, G. (2012, April 3). The role of myeloid cells in HIV associated immune reconstitution inflammatory syndrome [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/TAUO6951.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Robert Wilkinson has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
- Prof. Graeme Meintjes has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Hide